Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Ends a Phase 2 Study for Antibody
WSJ Online
Wed, 01/6/16 - 08:00 pm
Tags:
Gilead Sciences, simtuzumab, pancreatic cancer
Gilead grabs priority review for pangenotype hep C combo; Hep B med shown to be safe
BioPharma Dive
Wed, 01/6/16 - 11:01 am
Tags:
Gilead Sciences, hepatitis C, hepatitis B, Sovaldi + velpatasvir, Viread
3 Potential Blockbuster Drugs Launching in 2016
Investors.com
Wed, 01/6/16 - 10:57 am
Tags:
Merck, hepatitis C, elbasvir/grazoprevir, Gilead Sciences, sofosbuvir/velpatasvir, Eli Lilly, psoriasis, ixekizumab
Gilead gets FDA priority review of Hepatitis C combo drug
Marketwatch
Tue, 01/5/16 - 09:06 am
Tags:
Gilead Sciences, FDA, priority review, hepatitis C, Sovaldi-velpatasir
What Does 2016 Hold for Biotech Stocks?
Motley Fool
Sun, 01/3/16 - 10:27 pm
Tags:
biotech, Gilead Sciences, Celgene, Amgen, Regeneron, Sanofi, Biomarin, Sarepta Th
Can Gilead Sciences Save Key Pipeline Blockbusters from Rivals?
Bidness, ETC
Sat, 01/2/16 - 10:16 am
Tags:
Gilead Sciences, simtuzumab, NASH, JAK inhibitors, filgotinib
Reviewing Gilead's Latest Pipeline News: Focus On Oncology And The Galapagos Deal
Seeking Alpha
Fri, 01/1/16 - 08:35 pm
Tags:
Gilead Sciences, oncology, R&D, Galapagos
Why Did Gilead Sciences, Inc. Take on a Mountain of Debt?
Motley Fool
Fri, 01/1/16 - 11:20 am
Tags:
Gilead Sciences, debt
Gilead, Amgen, Shire: Key Bolt-On Biotech Deal Makers for 2016
Bidness, ETC
Thu, 12/31/15 - 10:24 am
Tags:
Shire, Amgen, Gilead Sciences, M&A
Gilead Faces Troubled HCV Scripts as AbbVie Scripts Go Up
Bidness, ETC
Wed, 12/30/15 - 07:07 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C, Sovaldi, Harvoni, Viekira Pak
How Gilead Sciences M&A Can Pan Out Next Year
Bidness, ETC
Tue, 12/29/15 - 09:36 am
Tags:
Gilead Sciences, M&A, Vertex Pharmaceuticals, Incyte, Biomarin, Regeneron
The Price Keeps Falling For a Superstar Gilead Drug in India
Bloomberg
Tue, 12/29/15 - 09:33 am
Tags:
India, Gilead Sciences, sofosbuvir, Sovaldi, hepatitis C
What Happened in Biotech in 2015?
Motley Fool
Tue, 12/29/15 - 09:30 am
Tags:
biotech, Turing Pharmaceuticals, Valeant Pharmaceuticals, Gilead Sciences, drug pricing, M&A, Celgene, Receptos, drug approvals
Will Gilead Turn The Corner In 2016?
Seeking Alpha
Mon, 12/28/15 - 04:29 pm
Tags:
Gilead Sciences
Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Tags:
Gilead Sciences, JAK inhibitors, Pfizer, Eli Lilly, filgotinib, Galapagos, Xeljanz, baricitinib
3 New Drugs Ready to Explode in 2016
Motley Fool
Sat, 12/26/15 - 08:43 pm
Tags:
Vertex Pharmaceuticals, Orkambi, Gilead Sciences, Genvoya, Novartis, Entresto
Is Merck & Co. About to Derail Gilead Sciences?
Motley Fool
Tue, 12/22/15 - 09:59 pm
Tags:
Merck, Gilead Sciences, grazoprevir/elbasvir, Viekira Pak, AbbVie
What Does Gilead Want to Do?
Barron's
Mon, 12/21/15 - 02:52 pm
Tags:
Gilead Sciences
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Bidness, ETC
Sun, 12/20/15 - 04:45 pm
Tags:
Gilead Sciences, AstraZeneca, AbbVie, filgotinib, Acerta Pharma, Galapagos
Belgium's Galapagos signs $2 bln deal with U.S. company Gilead
Yahoo/Reuters
Thu, 12/17/15 - 09:50 am
Tags:
Belgium, Galapagos, Gilead Sciences, filgotinib, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.